We read the recently published paper on service user involvement with qualitative analysis \[[@CR1]\] with interest as we are a public involvement group informing a study about patient-held information about medicines \[[@CR2]\] and have recently undertaken analysis of some of the qualitative data from this study. Our group has used a very similar approach to that taken in another previous project \[[@CR3]\], cited by Locock et al. We agree with Locock et al. \[[@CR1]\] that conversation is at the heart of productive public involvement, but don't necessarily agree that "conversation rather than data is at the heart of user involvement in analysis". We feel that asking public contributors to identify touchpoints from their own experience to direct the focus of researchers undertaking analysis occupies an uneasy space between involvement and study participation.

We have not had the difficulties that that Locock et al. \[[@CR1]\] encountered, and therefore disagree with their conclusion that the public might struggle to analyse raw data. We remain wedded to the idea that the data should remain at the heart of the analysis and argue that members of the public can realistically and meaningfully contribute to this. We agree with Locock et al's \[[@CR1]\] reflection that they may have been unrealistic in the demands that they placed on their public contributors. Education, training and completion of a novel task is a huge undertaking in 1 day, especially in groups for whom fatigue is a well-known problem. This may have been compounded in a group whose members did not already know each other.

Our involvement group has been active since the start of the study and knows the project well. Group dynamics are understood; we do not need to hear each other's stories to validate our own experiences. We agreed how we wished to approach the analysis which included the following stages; a 2 h training session on analysis and a particular theory, distribution of anonymised scripts for us to consider at home in our own time, and then a meeting on a later date to discuss the themes found. Notes on our findings were taken by the researcher and subsequently compared with hers. As Locock et al. \[[@CR1]\] found, most themes were similar, but with some differences of emphasis.

We would therefore like to suggest that the problems that Locock et al. \[[@CR1]\] encountered could be addressed by embedding involvement in analysis into involvement in the project as a whole, and by breaking down the task into sections over a longer time period, rather than dissociating the analysis from the data.
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